113 related articles for article (PubMed ID: 17124068)
1. Myeloproliferative disease in pregnancy and other management issues.
Barbui T; Finazzi G
Hematology Am Soc Hematol Educ Program; 2006; ():246-52. PubMed ID: 17124068
[TBL] [Abstract][Full Text] [Related]
2. Fertility, pregnancy and the management of myeloproliferative disorders.
Griesshammer M; Bergmann L; Pearson T
Baillieres Clin Haematol; 1998 Dec; 11(4):859-74. PubMed ID: 10640221
[TBL] [Abstract][Full Text] [Related]
3. Special issues in myeloproliferative neoplasms.
Barbui T; Finazzi G
Curr Hematol Malig Rep; 2011 Mar; 6(1):28-35. PubMed ID: 21181458
[TBL] [Abstract][Full Text] [Related]
4. [Approach to special issues associated with myeloproliferative neoplasms].
Kameda T; Shide K; Kubuki Y
Rinsho Ketsueki; 2015 Aug; 56(8):972-80. PubMed ID: 26345555
[TBL] [Abstract][Full Text] [Related]
5. A spotlight on the management of complications associated with myeloproliferative neoplasms: a clinician's perspective.
Greenfield G; McMullin MF
Expert Rev Hematol; 2018 Jan; 11(1):25-35. PubMed ID: 29183180
[TBL] [Abstract][Full Text] [Related]
6. Myeloproliferative disorders in pregnancy.
Harrison CN; Robinson SE
Hematol Oncol Clin North Am; 2011 Apr; 25(2):261-75, vii. PubMed ID: 21444029
[TBL] [Abstract][Full Text] [Related]
7. Bleeding and thrombosis in myeloproliferative disorders: mechanisms and treatment.
Landolfi R; Rocca B; Patrono C
Crit Rev Oncol Hematol; 1995 Oct; 20(3):203-22. PubMed ID: 8748010
[No Abstract] [Full Text] [Related]
8. Diagnosis, prevention, and management of bleeding episodes in Philadelphia-negative myeloproliferative neoplasms: recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society of Thrombosis and Hemostasis Research (GTH).
Appelmann I; Kreher S; Parmentier S; Wolf HH; Bisping G; Kirschner M; Bergmann F; Schilling K; Brümmendorf TH; Petrides PE; Tiede A; Matzdorff A; Griesshammer M; Riess H; Koschmieder S
Ann Hematol; 2016 Apr; 95(5):707-18. PubMed ID: 26916570
[TBL] [Abstract][Full Text] [Related]
9. Management of MPN beyond JAK2.
Harrison CN; Garcia NC
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):348-54. PubMed ID: 25696878
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic dilemmas: balancing the risks of bleeding, thrombosis, and leukemic transformation in myeloproliferative disorders (MPD).
Murphy S
Thromb Haemost; 1997 Jul; 78(1):622-6. PubMed ID: 9198227
[TBL] [Abstract][Full Text] [Related]
11. [Surgical interventions in patients with myeloproliferative disease--prophylaxis and treatment of haemostatic disorders].
Dulícek P; Voglová J; Malý J
Vnitr Lek; 2010 Jan; 56(1):61-6. PubMed ID: 20184114
[TBL] [Abstract][Full Text] [Related]
12. Budd-Chiari syndrome and portal vein thrombosis associated with myeloproliferative disorders: diagnosis and management.
Brière JB
Semin Thromb Hemost; 2006 Apr; 32(3):208-18. PubMed ID: 16673275
[TBL] [Abstract][Full Text] [Related]
13. Acquired von Willebrand factor abnormalities in myeloproliferative disorders and other hematologic diseases: a retrospective analysis by a single institution.
Sánchez-Luceros A; Meschengieser SS; Woods AI; Blanco AN; Kempfer AC; Casais P; Salviú MJ; Lazzari MA
Haematologica; 2002 Mar; 87(3):264-70. PubMed ID: 11869938
[TBL] [Abstract][Full Text] [Related]
14. Relation of platelet abnormalities to thrombosis and hemorrhage in chronic myeloproliferative disorders.
Wehmeier A; Südhoff T; Meierkord F
Semin Thromb Hemost; 1997; 23(4):391-402. PubMed ID: 9263357
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and treatment of BCR/ABL-negative myeloproliferative diseases--principles and rationale of CZEMP recommendations].
Schwarz J; Penka M; Campr V; Pospísilová D; Kren L; Nováková L; Bodzásová C; Brychtová Y; Cerná O; Dulícek P; Joniásová A; Kissová J; Korístek Z; Schützová M; Vonke I; Walterová L
Vnitr Lek; 2011 Feb; 57(2):189-213. PubMed ID: 21416861
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy and its management in the Philadelphia negative myeloproliferative diseases.
Harrison C
Br J Haematol; 2005 May; 129(3):293-306. PubMed ID: 15842653
[TBL] [Abstract][Full Text] [Related]
17. Myeloproliferative disorders--neurological complications.
Tarach JS; Nowicka-Tarach BM
Med Sci Monit; 2000; 6(2):421-5. PubMed ID: 11208349
[TBL] [Abstract][Full Text] [Related]
18. Thrombohemorrhagic complications of myeloproliferative disorders.
Papadakis E; Hoffman R; Brenner B
Blood Rev; 2010 Nov; 24(6):227-32. PubMed ID: 20817333
[TBL] [Abstract][Full Text] [Related]
19. Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European Leukemia Net study.
Martinelli I; De Stefano V; Carobbio A; Randi ML; Santarossa C; Rambaldi A; Finazzi MC; Cervantes F; Arellano-Rodrigo E; Rupoli S; Canafoglia L; Tieghi A; Facchini L; Betti S; Vannucchi AM; Pieri L; Cacciola R; Cacciola E; Cortelezzi A; Iurlo A; Pogliani EM; Elli EM; Spadea A; Barbui T
Am J Hematol; 2014 Nov; 89(11):E200-5. PubMed ID: 25042466
[TBL] [Abstract][Full Text] [Related]
20. Intrauterine diagnosis and management of transient myeloproliferative disorder.
Strobelt N; Ghidini A; Locatelli A; Vergani P; Mariani S; Biondi A
Am J Perinatol; 1995 Mar; 12(2):132-4. PubMed ID: 7779196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
